FAQ

Documents

Known as: Doc, document 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1946-2017
010203019462016

Related topics

Related topics

30 relations
Blood glucose monitors attachment:Finding:Point in time:^Patient:DocumentDocument typeDocumentedEmployee assistance program attachment:Finding:Point in time:^Patient:Document
(More)

Related mentions per year

Related mentions per year

1943-2018
19401960198020002020
Documents
Documented
Oxygen attachment:Finding:Point in time:^Patient:Document
Views:Finding:Point in time:Chest:Narrative:XR
Document type
Prescriptions:Finding:Point in time:^Patient:Narrative

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised…
BACKGROUND Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2014
2014
Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment.
BACKGROUND Enzalutamide (Enz) and abiraterone acetate (AA) are hormone treatments that have a proven survival advantage in… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men.
OBJECTIVE Sarcopenia of legs is an important cause of physical dysfunctions, frailty and dependence. Many predisposing and… (More)
  • figure 1
  • table 1
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Allostery and Intrinsic Disorder Mediate Transcription Regulation by Conditional Cooperativity
Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Fido, a Novel AMPylation Domain Common to Fic, Doc, and AvrB
BACKGROUND The Vibrio parahaemolyticus type III secreted effector VopS contains a fic domain that covalently modifies Rho GTPase… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation.
Prokaryotic toxin-antitoxin modules are involved in major physiological events set in motion under stress conditions. The toxin… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.
PURPOSE Primary systemic therapy (PST) with gemcitabine (G), epirubicin (E), and docetaxel (Doc) has resulted in a pathologic… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Addiction protein Phd of plasmid prophage P1 is a substrate of the ClpXP serine protease of Escherichia coli.
Plasmid-encoded addiction genes augment the apparent stability of various low copy number bacterial plasmids by selectively… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Plasmid addiction genes of bacteriophage P1: doc, which causes cell death on curing of prophage, and phd, which prevents host death when prophage is retained.
P1 lysogens of Escherichia coli carry the prophage as a stable low copy number plasmid. The frequency with which viable cells… (More)
Is this relevant?
1993
1993
Doc and copia instability in an isogenic Drosophila melanogaster stock
A high degree of heterogeneity and an overall increase in number of insertion sites of the mobile elements Doc and copia were… (More)
  • table 1
  • table 2
Is this relevant?